11 July 2024
11 July 2024
XyloCor will pay approximately $130m in upfront and milestone-based payments to SmartCella for the supply of Extroducer infusion system.
PFA procedures are surging in the electrophysiology ablation sector, as key medtech players battle for market share.
The Adona adjustable device is equipped with a shunt, which features a flow channel with an adaptable geometry.
Patients can use their existing smartphones to facilitate the mobile-first, data-driven pre-screening process.
Moving into the operating room for the first time, the company’s set of augmented reality planning tools now allows for real-time surgical assistance.
Researchers evaluated 12 validation studies, finding that the test detects low levels of specific RNA markers and maintains accuracy.
Cosmotec will manage the Japanese regulatory approval process for the device.
The H-optimus-0 model's extensive training enables it to perform at advance levels in medical diagnostic tasks.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
